{"id":"https://openalex.org/W7225575369","doi":"https://doi.org/10.37557/ps48an05","title":"PHARMACOVIGILANCE IN PRACTICE: ASSESSMENT OF REPORTED SERIOUS ADVERSE DRUG EVENTS IN NINEVEH HEALTH INSTITUTIONS","display_name":"PHARMACOVIGILANCE IN PRACTICE: ASSESSMENT OF REPORTED SERIOUS ADVERSE DRUG EVENTS IN NINEVEH HEALTH INSTITUTIONS","publication_year":2026,"publication_date":"2026-11-08","ids":{"openalex":"https://openalex.org/W7225575369","doi":"https://doi.org/10.37557/ps48an05"},"language":"en","primary_location":{"id":"doi:10.37557/ps48an05","doi":"https://doi.org/10.37557/ps48an05","is_oa":true,"landing_page_url":"https://doi.org/10.37557/ps48an05","pdf_url":"https://www.gjphm.org/index.php/gjphm/article/download/411/180","source":{"id":"https://openalex.org/S4210212039","display_name":"Global Journal of Public Health Medicine","issn_l":"2664-4657","issn":["2664-4657"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Global Journal of Public Health Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.gjphm.org/index.php/gjphm/article/download/411/180","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106327014","display_name":"Abdulnaser J. A. Almustafa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdulnaser J. A. Almustafa","raw_affiliation_strings":["Department of Pharmacy, Nineveh Health Directorate, Mosul, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Nineveh Health Directorate, Mosul, Iraq","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161297557","display_name":"Mustafa B. Al-Khyat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mustafa B. Al-Khyat","raw_affiliation_strings":["Department of Pharmacy, Nineveh Health Directorate, Mosul, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Nineveh Health Directorate, Mosul, Iraq","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022524738","display_name":"Hasan Saad Aldewachi","orcid":"https://orcid.org/0000-0003-2126-4366","observed_orcids":["https://orcid.org/0000-0003-2126-4366"]},"institutions":[{"id":"https://openalex.org/I4405259204","display_name":"Ninevah University","ror":"https://ror.org/01x7tft50","country_code":"IQ","type":"education","lineage":["https://openalex.org/I4405259204"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Hasan S. Aldewachi","raw_affiliation_strings":["Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Nineveh University, Mosul, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Nineveh University, Mosul, Iraq","institution_ids":["https://openalex.org/I4405259204"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":100,"currency":"USD","value_usd":100},"apc_paid":{"value":100,"currency":"USD","value_usd":100},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"1 (Ongoing)","first_page":"270","last_page":"286"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serious-adverse-drug-reactions","display_name":"serious adverse drug reactions","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9710000157356262},{"id":"https://openalex.org/keywords/individual-case-safety-reports","display_name":"individual case safety reports","score":0.8769999742507935},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8149999976158142},{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cephalosporin-hypersensitivity","display_name":"cephalosporin hypersensitivity","score":0.8600000143051147},{"id":"https://openalex.org/keywords/drug-causality-assessment","display_name":"drug causality assessment","score":0.6830000281333923},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.3610000014305115},{"id":"https://openalex.org/keywords/nineveh","display_name":"Nineveh","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.947700023651123},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.861299991607666},{"id":"https://openalex.org/C199475168","wikidata":"https://www.wikidata.org/wiki/Q1539689","display_name":"MedDRA","level":4,"score":0.7786999940872192},{"id":"https://openalex.org/C64357122","wikidata":"https://www.wikidata.org/wiki/Q1149766","display_name":"Causality (physics)","level":2,"score":0.5414000153541565},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5221999883651733},{"id":"https://openalex.org/C2776650110","wikidata":"https://www.wikidata.org/wiki/Q12891156","display_name":"Seriousness","level":2,"score":0.5047000050544739},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.49149999022483826},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4465999901294708},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.42160001397132874},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.4133000075817108},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.40540000796318054},{"id":"https://openalex.org/C137627325","wikidata":"https://www.wikidata.org/wiki/Q156318","display_name":"Etiology","level":2,"score":0.33959999680519104},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.33660000562667847},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.33079999685287476},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.3257000148296356},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.30809998512268066},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.3027999997138977},{"id":"https://openalex.org/C2781342390","wikidata":"https://www.wikidata.org/wiki/Q17146321","display_name":"Under-reporting","level":2,"score":0.29840001463890076},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.28450000286102295},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.2793999910354614},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.2768999934196472},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.26600000262260437},{"id":"https://openalex.org/C2776231263","wikidata":"https://www.wikidata.org/wiki/Q722387","display_name":"Tilmicosin","level":3,"score":0.2619999945163727},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25929999351501465},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.25450000166893005}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.37557/ps48an05","doi":"https://doi.org/10.37557/ps48an05","is_oa":true,"landing_page_url":"https://doi.org/10.37557/ps48an05","pdf_url":"https://www.gjphm.org/index.php/gjphm/article/download/411/180","source":{"id":"https://openalex.org/S4210212039","display_name":"Global Journal of Public Health Medicine","issn_l":"2664-4657","issn":["2664-4657"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Global Journal of Public Health Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.37557/ps48an05","doi":"https://doi.org/10.37557/ps48an05","is_oa":true,"landing_page_url":"https://doi.org/10.37557/ps48an05","pdf_url":"https://www.gjphm.org/index.php/gjphm/article/download/411/180","source":{"id":"https://openalex.org/S4210212039","display_name":"Global Journal of Public Health Medicine","issn_l":"2664-4657","issn":["2664-4657"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Global Journal of Public Health Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225575369.pdf","grobid_xml":"https://content.openalex.org/works/W7225575369.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3188810570","https://openalex.org/W4407480038","https://openalex.org/W7223686573","https://openalex.org/W2807500288","https://openalex.org/W7215610534","https://openalex.org/W3109902355","https://openalex.org/W7161141704","https://openalex.org/W4407925552","https://openalex.org/W6967963414","https://openalex.org/W3109003816"],"abstract_inverted_index":{"Introduction:":[0],"Serious":[1],"adverse":[2],"drug":[3,122],"reactions":[4,125],"(SADRs)":[5],"cause":[6],"significant":[7],"morbidity":[8],"and":[9,21,30,57,85,92,112,152,160,177,193],"mortality.":[10],"This":[11,34],"study":[12,36],"describes":[13],"SADRs":[14,170],"reported":[15,169],"to":[16,168],"the":[17,46,64,97,106,119,184],"Nineveh":[18,47],"pharmacovigilance":[19,188],"system":[20],"evaluates":[22],"patient":[23],"demographics,":[24],"implicated":[25,121],"drugs,":[26],"affected":[27,99],"organ":[28,100],"classes,":[29,101],"clinical":[31],"outcomes.":[32],"Methods:":[33],"cross-sectional":[35],"analyzed":[37],"spontaneous":[38],"serious":[39],"individual":[40],"case":[41],"safety":[42],"reports":[43,81],"(ICSRs)":[44],"in":[45,150,154,171],"VigiFlow.":[48],"database":[49],"during":[50],"2025.":[51],"Data":[52],"were":[53,96,118,126],"coded":[54],"using":[55],"MedDRA":[56],"ATC":[58],"classifications,":[59],"with":[60,102],"causality":[61],"assessed":[62],"via":[63],"WHO-UMC":[65],"system.":[66],"Results:":[67],"Of":[68],"1,300":[69],"ICSRs,":[70],"419":[71],"(32.2%)":[72],"met":[73],"WHO":[74],"seriousness":[75],"criteria,":[76],"encompassing":[77],"897":[78],"SADRs.":[79],"Most":[80,124],"involved":[82],"females":[83],"(70.2%)":[84],"adults":[86],"aged":[87],"18\u201364":[88],"(62.3%).":[89],"Skin/subcutaneous":[90],"(15.5%)":[91],"respiratory/thoracic":[93],"(13.8%)":[94],"disorders":[95],"most":[98,107,120],"dyspnea":[103],"(11.0%)":[104],"being":[105],"frequent":[108],"presentation.":[109],"Antineoplastics":[110,159],"(45.7%)":[111],"systemic":[113,161],"anti-infectives":[114],"(23.9%,":[115],"predominantly":[116],"ceftriaxone)":[117,164],"classes.":[123],"life-threatening":[127],"(31.5%)":[128],"or":[129],"required":[130],"hospitalization":[131],"(27.5%).":[132],"While":[133],"64.7%":[134],"of":[135,156],"patients":[136],"recovered,":[137],"three":[138],"fatalities":[139],"(0.7%)":[140],"occurred":[141],"following":[142],"parenteral":[143],"cephalosporin":[144],"administration.":[145],"Causality":[146],"was":[147],"deemed":[148],"probable":[149],"49.6%":[151],"possible":[153],"40.4%":[155],"cases.":[157],"Conclusion:":[158],"antibiotics":[162],"(especially":[163],"are":[165],"primarily":[166],"linked":[167],"Nineveh,":[172],"frequently":[173],"presenting":[174],"as":[175],"skin":[176],"respiratory":[178],"hypersensitivity":[179],"reactions.":[180],"These":[181],"findings":[182],"emphasize":[183],"need":[185],"for":[186],"enhanced":[187],"training,":[189],"rational":[190],"antimicrobial":[191],"prescribing,":[192],"targeted":[194],"medication-error":[195],"prevention.":[196]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-09T00:00:00"}